Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stockholm - Delayed Quote SEK

Zenicor Medical Systems AB (ZENI.ST)

Compare
2.2400
+0.2700
+(13.71%)
At close: April 4 at 5:05:10 PM GMT+2
Loading Chart for ZENI.ST
  • Previous Close 1.9700
  • Open 1.8800
  • Bid 1.9200 x --
  • Ask 2.2400 x --
  • Day's Range 1.8700 - 2.2400
  • 52 Week Range 1.5100 - 3.0800
  • Volume 37,000
  • Avg. Volume 4,595
  • Market Cap (intraday) 20.211M
  • Beta (5Y Monthly) 1.03
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor-ECG, a system to detect and diagnose atrial fibrillation and other arrhythmias, as well as allows the patient to register ECG data during extended periods and transfer the date to a central ECG database, where the data is presented to the care provider through the Internet. It serves cardiology, stroke, medical, pediatrics, clinical physiology, and private clinics in the Nordics, Germany, Switzerland, Austria, Cyprus, and the Great Britain. The company was incorporated in 2003 and is headquartered in Stockholm, Sweden.

zenicor.se

18

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZENI.ST

View More

Performance Overview: ZENI.ST

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ZENI.ST
26.55%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

ZENI.ST
27.27%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

ZENI.ST
91.78%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

ZENI.ST
71.68%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: ZENI.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZENI.ST

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    20.21M

  • Enterprise Value

    32.04M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.80

  • Price/Book (mrq)

    0.71

  • Enterprise Value/Revenue

    1.27

  • Enterprise Value/EBITDA

    7.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.96%

  • Return on Assets (ttm)

    0.12%

  • Return on Equity (ttm)

    -7.06%

  • Revenue (ttm)

    29.96M

  • Net Income Avi to Common (ttm)

    -2.08M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    911.7k

  • Total Debt/Equity (mrq)

    74.92%

  • Levered Free Cash Flow (ttm)

    -6.84M

Research Analysis: ZENI.ST

View More

Company Insights: ZENI.ST

Research Reports: ZENI.ST

View More

People Also Watch